Science & Enterprise subscription

Follow us on Twitter

  • New contributed post on Science and Enterprise: https://t.co/X0lcOr1s58 Low-Carbon Solutions Set to Change the World
    about 3 hours ago
  • A company developing a system with artificial intelligence to analyze medical literature for treatment insights is… https://t.co/TdK2vtumZo
    about 19 hours ago
  • New post on Science and Enterprise: Medical Knowledge A.I. Company Raises Early $4.8M https://t.co/lqYHuWQs7g #Science #Business
    about 19 hours ago
  • New contributed post on Science and Enterprise: https://t.co/3Gofb2uiDv Guidelines for Training New Employees
    about 22 hours ago
  • Regenstrief Institute, affiliated with Indiana University, is investing in a new company aiming to improve long-ter… https://t.co/87KTKEoWp8
    about 23 hours ago

Please share Science & Enterprise

Infographic – Key Health Care/A.I. Start-Ups

AI-health care start-ups

Click on image for full-size view (CB Insights)

28 Sept. 2019. Regular readers of Science & Enterprise know we give a lot of attention to artificial intelligence, its growing use in science, and emergence in products and services spun-off from research labs. Earlier this month, our friends at CB Insights compiled a list of start-up companies applying A.I. to health care, with its market map of these enterprises making up our weekend infographic.

The market map shows 84 new companies working with A.I. in health care, although the accompanying report adds a few more. CB Insights breaks down the companies into 12 categories:

– Imaging and diagnostics
– Drug discovery
– Predictive analytics and risk scoring
– Genomics
– Virtual assistant
– Hospital decision support
– Remote monitoring
– Clinical trials
– Fitness
– Nutrition
– Compliance (e.g. protecting patient data)
– Mental health

Imaging-diagnostics and drug discovery are the two main groupings, taking up more than half of the enterprises on the chart. CB Insights points out that the imaging and diagnostics category accounts for $1.5 billion or 22 percent of investor financing, while the drug discovery group gained 23 percent of investment funding. And while six in 10 of these companies are based in the U.S., China and the U.K. are emerging as key start-up hubs for A.I. in health care.

More from Science & Enterprise:

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.